Brief: Corline Biomedical Q3 pre-tax loss widens to SEK 1.3 million
Nov 17 (Reuters) - Corline Biomedical AB CLBIO.ST :
* Q3 net sales 158,000 Swedish crowns ($17,217) versus 232,000 crowns year ago
* Q3 pre-tax loss 1.3 million crowns versus loss 1.1 million crowns year ago
Source text for Eikon: ID:nGNE4lc34Q
Further company coverage: CLBIO.ST
($1 = 9.1768 Swedish crowns)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln